Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Asset Resilience Ratio

Latest as of March 2024: -0.13%

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has an Asset Resilience Ratio of -0.13% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 002864 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥-2.77 Million
≈ $-404.62K USD Cash + Short-term Investments

Total Assets

CN¥2.19 Billion
≈ $320.38 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2023)

This chart shows how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's Asset Resilience Ratio has changed over time. See Shaanxi Panlong Pharmaceutical Group Lim (002864) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Shaanxi Panlong Pharmaceutical Group Lim worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥-2.77 Million -0.13%
Total Liquid Assets CN¥-2.77 Million -0.13%

Asset Resilience Insights

  • Limited Liquidity: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A maintains only -0.13% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2019–2023)

The table below shows the annual Asset Resilience Ratio data for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -0.13% CN¥-2.87 Million
≈ $-419.60K
CN¥2.13 Billion
≈ $310.96 Million
+0.47pp
2022-12-31 -0.61% CN¥-11.77 Million
≈ $-1.72 Million
CN¥1.93 Billion
≈ $282.53 Million
-0.72pp
2021-12-31 0.11% CN¥1.48 Million
≈ $217.12K
CN¥1.33 Billion
≈ $194.65 Million
-5.29pp
2019-12-31 5.41% CN¥50.21 Million
≈ $7.35 Million
CN¥928.88 Million
≈ $135.92 Million
--
pp = percentage points

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic
Market Cap
$470.30 Million
CN¥3.21 Billion CNY
Market Cap Rank
#12840 Global
#4018 in China
Share Price
CN¥30.24
Change (1 day)
-0.23%
52-Week Range
CN¥26.92 - CN¥39.20
All Time High
CN¥74.44
About

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more